Updated:
TRANSKARYOTIC THERAPIES INC
TRANSKARYOTIC THERAPIES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000885259, and its reported...
Overview
TRANSKARYOTIC THERAPIES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000885259, and its reported industry is Biological Products, (No Diagnostic Substances). The retained history contains 12 filings, including SC 13G filed on 2006-02-10. Each filing retains its accession, filing date and original SEC document link. This historical evidence does not establish current registration, listing, ownership or financial condition.
Company overview
- Legal name
- TRANSKARYOTIC THERAPIES INC
- Classification
- Company
- Industry (SIC)
- 2836 — Biological Products, (No Diagnostic Substances)
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0000885259
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| SC 13G | — | Form SC 13G | |
| SC 13D | — | Form SC 13D | |
| SC 13G | — | INITIAL FILING | |
| SC 13G | — | Form SC 13G | |
| SC 13D | — | Form SC 13D | |
| 10-Q | FORM 10-Q - TRANSKATYOTIC THERAPIES, INC. | ||
| 8-K | TRANSKARYOTIC THERAPIES, INC. | ||
| 10-K/A | TRANSKARYOTIC THERAPIES, INC. FORM 10-K/A | ||
| SC 13D | — | Form SC 13D | |
| 8-K | TRANSKARYOTIC THERAPIES, INC. FORM 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research TRANSKARYOTIC THERAPIES INC in Altss
Track this company’s investors, transactions and relationships in Altss.